Deerfield Management’s Ortho Clinical Diagnostics Holdings OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-2,352,941
Closed -$45.4M – 163
2021
Q1
$45.4M Buy
+2,352,941
New +$41.5M 0.95% 32

Other funds holding OCDX

Deerfield Management's OCDX Position: Q2 2021 in Review

Deerfield Management sold out of Ortho Clinical Diagnostics Holdings (OCDX) in Q2 2021, closing a stake of 2,352,941 shares — an estimated $45.4M sold.

Deerfield Management first reported a position in OCDX in Q1 2021 and held it in 1 quarter. The position peaked at $45.4M in Q1 2021. 106 funds tracked by Wall St. Rank hold OCDX as of Q2 2021.

  • Deerfield Management reported no remaining Ortho Clinical Diagnostics Holdings position as of Q2 2021 after selling out during the quarter.
  • Deerfield Management sold 2,352,941 Ortho Clinical Diagnostics Holdings shares in Q2 2021, an estimated $45.4M.
  • Deerfield Management first reported a position in Ortho Clinical Diagnostics Holdings in Q1 2021 and held it in 1 quarter.
  • Deerfield Management's Ortho Clinical Diagnostics Holdings position peaked at $45.4M in Q1 2021.
  • 106 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings as of Q2 2021.

Based on Deerfield Management's 13F filing for Q2 2021, filed 16 Aug 2021.